StockData
Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX) stock

HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$0.28−0.00 (-0.74%)

Close on Nov 17, 2026Market cap $53.58MP/E –Yield –

Heron Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Heron Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -22.5%. For fiscal 2025 it was -13.0%, against -9.4% the year before. The highest annual figure on record is -9.4% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-13.0%−3.6
FY2024Dec 31, 2024-9.4%+77.6
FY2023Dec 31, 2023-87.0%+82.0
FY2022Dec 31, 2022-169.1%+86.5
FY2021Dec 31, 2021-255.6%+0.8
FY2020Dec 31, 2020-256.4%−116.1
FY2019Dec 31, 2019-140.3%+90.6
FY2018Dec 31, 2018-230.8%+411.0
FY2017Dec 31, 2017-641.9%+12895.5
FY2016Dec 31, 2016-13537.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-14.6%−8.2
Q1 FY2026Mar 31, 2026-23.4%−30.1
Q4 FY2025Dec 31, 2025-7.3%−16.3
Q3 FY2025Sep 30, 2025-45.8%−31.0
Q2 FY2025Jun 30, 2025-6.4%+19.2
Q1 FY2025Mar 31, 20256.8%+15.9
Q4 FY2024Dec 31, 20249.0%+40.3
Q3 FY2024Sep 30, 2024-14.8%+64.8
Q2 FY2024Jun 30, 2024-25.6%+106.8
Q1 FY2024Mar 31, 2024-9.1%+101.5
Q4 FY2023Dec 31, 2023-31.3%+34.8
Q3 FY2023Sep 30, 2023-79.6%+78.2
Q2 FY2023Jun 30, 2023-132.4%+71.6
Q1 FY2023Mar 31, 2023-110.6%+161.7
Q4 FY2022Dec 31, 2022-66.2%+198.4
Q3 FY2022Sep 30, 2022-157.8%+67.8
Q2 FY2022Jun 30, 2022-204.0%+67.9
Q1 FY2022Mar 31, 2022-272.4%−9.5
Q4 FY2021Dec 31, 2021-264.6%+37.7
Q3 FY2021Sep 30, 2021-225.6%+66.0
Q2 FY2021Jun 30, 2021-271.9%−28.4
Q1 FY2021Mar 31, 2021-262.8%−59.8
Q4 FY2020Dec 31, 2020-302.3%−137.2
Q3 FY2020Sep 30, 2020-291.7%−212.8
Q2 FY2020Jun 30, 2020-243.5%−106.5
Q1 FY2020Mar 31, 2020-203.1%−3.7
Q4 FY2019Dec 31, 2019-165.1%+6.7
Q3 FY2019Sep 30, 2019-78.8%+115.0
Q2 FY2019Jun 30, 2019-137.0%+86.8
Q1 FY2019Mar 31, 2019-199.4%+252.5
Q4 FY2018Dec 31, 2018-171.8%+449.8
Q3 FY2018Sep 30, 2018-193.8%+294.6
Q2 FY2018Jun 30, 2018-223.8%+279.1
Q1 FY2018Mar 31, 2018-451.8%+933.9
Q4 FY2017Dec 31, 2017-621.6%+3128.4
Q3 FY2017Sep 30, 2017-488.4%–
Q2 FY2017Jun 30, 2017-502.9%–
Q1 FY2017Mar 31, 2017-1385.7%–
Q4 FY2016Dec 31, 2016-3750.0%–

More Heron Therapeutics figures

See a number that looks wrong?